Eight-year follow up results of the OTOASOR Trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer. A randomized, single centre, phase III, non-inferiority trial

被引：0
|
作者：
Savolt, A. [1 ]
Peley, G. [2 ]
Csaba, P. [3 ]
Udvarhelyi, N. [4 ]
Kovacs, E. [5 ]
Gyorffy, B. [6 ]
Matrai, Z. [1 ]
机构：
[1] Natl Inst Oncol, Dept Breast & Sarcoma Surg, Budapest, Hungary
[2] Norfolk & Norwich Univ Hosp, Dept Gen Surg, Norwich, Norfolk, England
[3] Natl Inst Oncol, Ctr Radiotherapy, Budapest, Hungary
[4] Natl Inst Oncol, Dept Pathol, Budapest, Hungary
[5] Natl Inst Oncol, Dept Diagnost Imaging, Budapest, Hungary
[6] Hungarian Acad Sci, MTA TTK Momentum Canc Biomarker Res Grp, Budapest, Hungary
来源：
EUROPEAN JOURNAL OF CANCER | 2017年 / 72卷
关键词：
D O I：
10.1016/S0959-8049(17)30090-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1LBA
引用
收藏
页码：S1 / S1
页数：1
相关论文
共 36 条
  • [21] Laparoscopic sentinel node navigation surgery versus laparoscopic standard gastrectomy with lymph node dissection in early gastric cancer: Final three-year survival results of multicenter randomized controlled phase III trial (SENORITA trial).
    Ryu, Keun Won
    Kim, Young Woo
    Min, Jae Seok
    An, Ji Yeong
    Yoon, Hong Man
    Eom, Bang Wool
    Hur, Hoon
    Lee, Young Joon
    Cho, Gyu Seok
    Park, Youngkyu
    Jung, Mi Ran
    Park, Ji-Ho
    Hyung, Woo Jin
    Jeong, Sang-Ho
    Han, Mira
    Nam, Byung-Ho
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [22] 5-year follow-up of the safety, tolerability and efficacy of subcutaneous trastuzumab for the adjuvant treatment of HER2-positive early breast cancer. Results from the SafeHER Phase III trial
    Gligorov, J.
    Pivot, X.
    Ataseven, B.
    De Laurentiis, M.
    Llombart, A.
    Jung, K. H.
    Manikhas, A.
    Azim, H. A.
    Alexandrou, A.
    Gupta, K.
    Herraez-Baranda, L.
    Tosti, N.
    Restuccia, E.
    BREAST, 2021, 56 : S21 - S22
  • [23] Breast Conservative Surgery With and Without Radiotherapy in Patients Aged 55-75 With Early-Stage Breast Cancer: A Prospective Randomized Multicenter Trial Analysis After 90 Months of Medium Follow-Up
    Tinterri, Corrado
    Costa, Alberto
    Andreoli, Claudio
    Valagussa, Pinuccia
    Gatzemeier, Wolfgang
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : 3 - 4
  • [24] Impact of lymphedema on health-related quality of life in early-stage breast cancer patients treated breast conserving therapy with or without sentinel lymph node biopsy: 2-year results from the randomized controlled trial BOOG2013-08
    Wintraecken, V.
    Colier, E.
    van Roozendaal, L. M.
    Tjan-Heijnen, V. C. G.
    Simons, J. M.
    Strobbe, L. J. A.
    van Maaren, M. C.
    Boersma, L. J.
    Lobbes, M. B. I.
    van Dalen, T.
    Linn, S. C.
    Poortmans, P. M. P.
    de Vries, J.
    van Kuijk, S. M. J.
    de Wilt, J.
    Smidt, M. L.
    EUROPEAN JOURNAL OF CANCER, 2022, 175 : S51 - S51
  • [25] Breast-Conservative Surgery With and Without Radiotherapy in Patients Aged 55–75 Years With Early-Stage Breast Cancer: A Prospective, Randomized, Multicenter Trial Analysis After 108 Months of Median Follow-up
    C. Tinterri
    W. Gatzemeier
    A. Costa
    M. A. Gentilini
    V. Zanini
    L. Regolo
    C. Pedrazzoli
    E. Rondini
    C. Amanti
    G. Gentile
    M. Taffurelli
    P. Fenaroli
    C. Tondini
    G. Sacchetto
    P. Sismondi
    R. Murgo
    M. Orlandi
    E. Cianchetti
    C. Andreoli
    Annals of Surgical Oncology, 2014, 21 : 408 - 415
  • [26] Accelerated partial breast or whole breast irradiation after breast conservation surgery for patients with early breast cancer: 10-year follow up results of the APBI IMRT Florence randomized phase 3 trial
    Meattini, Icro
    Saieva, Calogero
    Lucidi, Sara
    lo Russo, Monica
    Scotti, Vieri
    Desideri, Isacco
    Marrazzo, Livia
    Simontacchi, Gabriele
    Mangoni, Monica
    Becherini, Carlotta
    Visani, Luca
    Paoletti, Lisa
    Moretti, Erica
    Triggiani, Luca
    Bernini, Marco
    Orzalesi, Lorenzo
    Sanchez, Luis
    Nori, Jacopo
    Pallotta, Stefania
    Bianchi, Simonetta
    Livi, Lorenzo
    CANCER RESEARCH, 2020, 80 (04)
  • [27] Breast-Conservative Surgery With and Without Radiotherapy in Patients Aged 55-75 Years With Early-Stage Breast Cancer: A Prospective, Randomized, Multicenter Trial Analysis After 108 Months of Median Follow-up
    Tinterri, C.
    Gatzemeier, W.
    Costa, A.
    Gentilini, M. A.
    Zanini, V.
    Regolo, L.
    Pedrazzoli, C.
    Rondini, E.
    Amanti, C.
    Gentile, G.
    Taffurelli, M.
    Fenaroli, P.
    Tondini, C.
    Sacchetto, G.
    Sismondi, P.
    Murgo, R.
    Orlandi, M.
    Cianchetti, E.
    Andreoli, C.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (02) : 408 - 415
  • [28] A randomized, double-blind, phase III, non-inferiority clinical trial comparing the efficacy and safety of TA4415V (a proposed Trastuzumab biosimilar) and Herceptin (Trastuzumab reference product) in HER2-positive early-stage breast Cancer patients
    Nodehi, Reza Safaei
    Kalantari, Behjat
    Raafat, Jahangir
    Ansarinejad, Nafiseh
    Moazed, Vahid
    Mortazavizadeh, Seyed Mohammad Reza
    Hosseinzadeh, Mehran
    Ghaderi, Bayazid
    Jenabian, Arash
    Qadyani, Mojtaba
    Haghighat, Shirin
    Allahyari, Abolghasem
    Mirzania, Mehrzad
    Seghatoleslami, Mohammad
    Payandeh, Mehrdad
    Alikhasi, Afsaneh
    Kafi, Hamidreza
    Shahi, Farhad
    BMC PHARMACOLOGY & TOXICOLOGY, 2022, 23 (01):
  • [29] A randomized, double-blind, phase III, non-inferiority clinical trial comparing the efficacy and safety of TA4415V (a proposed Trastuzumab biosimilar) and Herceptin (Trastuzumab reference product) in HER2-positive early-stage breast Cancer patients
    Reza Safaei Nodehi
    Behjat Kalantari
    Jahangir Raafat
    Nafiseh Ansarinejad
    Vahid Moazed
    Seyed Mohammad Reza Mortazavizadeh
    Mehran Hosseinzadeh
    Bayazid Ghaderi
    Arash Jenabian
    Mojtaba Qadyani
    Shirin Haghighat
    Abolghasem Allahyari
    Mehrzad Mirzania
    Mohammad Seghatoleslami
    Mehrdad Payandeh
    Afsaneh Alikhasi
    Hamidreza Kafi
    Farhad Shahi
    BMC Pharmacology and Toxicology, 23
  • [30] The potential impact of treatment variations on the results of radiotherapy of the internal mammary lymph node chain: A quality-assurance report on the dummy run of EORTC phase III randomized trial 22922/10925 in stage I-III breast cancer
    Poortmans, PMP
    Venselaar, JLM
    Struikmans, H
    Hurkmans, CW
    Davis, JB
    Huyskens, D
    van Tienhoven, G
    Vlaun, V
    Lagendijk, JJW
    Mijnheer, BJ
    De Winter, KA
    Van der Hulst, MH
    Van den Bogaert, WFC
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 49 (05): : 1399 - 1408
1234